Month: January 2023

SHANGHAI, China, Jan. 17, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the new drug application (“NDA”) for Deuremidevir Hydrobromide Tablets (project code: JT001/VV116, “VV116”), an oral nucleoside analog anti-SARS-CoV-2 drug, has been accepted by the National Medical Products Administration (the “NMPA”) for the treatment of the coronavirus disease 2019 (“COVID-19”). About Junshi BiosciencesFounded in December 2012, Junshi Biosciences (HKEX: 1877; SSE: 688180) is an innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapeutics. The company...

SHANGHAI, China, Jan. 18, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that a randomized, double-blind, placebo-controlled, multi-center phase III clinical study (“Neotorch”, NCT04158440) of the company’s anti-PD-1 monoclonal antibody, toripalimab, in combination with platinum-containing doublet chemotherapy as perioperative treatment for operable non-small cell lung cancer (“NSCLC”) patients, has finished the pre-specified interim analysis. The Independent Data Monitoring Committee (IDMC) has determined that the primary endpoint of event-free survival (“EFS”) has met the pre-defined efficacy boundary. Junshi Biosciences...

GREELEY, Colo., Jan. 17, 2023 (GLOBE NEWSWIRE) — Pilgrim’s Pride Corporation (NASDAQ: PPC) announced today that it will release its fourth quarter and fiscal year 2022 financial results after the U.S. market closes on Wednesday, February 8, 2023. The Company’s executives will review the results on a conference call and webcast on Thursday, February 9, 2023 at 7:00 a.m. MT (9:00 a.m. ET). Prepared remarks regarding the company’s financial and operational results will be followed by a question and answer period with Pilgrim’s executive management team. Investors and analysts may pre-register for the webcast to receive a unique PIN to gain immediate access to the call and bypass the live operator. Pre-registration may be completed at any time, including up to and after the call has begun, by accessing the company’s investor website...

MONTRÉAL, Jan. 17, 2023 (GLOBE NEWSWIRE) — Bombardier Inc. (“Bombardier”) today announced that it has successfully priced its offering of US$750 million aggregate principal amount of new Senior Notes due February 1, 2029. The new Senior Notes will carry a coupon of 7.50% per annum and will be sold at par (the “New Notes”). The issuance of the New Notes is expected to close on or about January 20, 2023, subject to customary closing conditions. Bombardier intends to use the proceeds of the offering of the New Notes, together with cash on hand, (i) to fund the redemption of all of its outstanding 7.500% Senior Notes due 2024 (the “2024 Notes”), of which there is $396 million aggregate principal amount outstanding on the date hereof, (ii) to finance the offer to purchase (the “2025 Tender Offer”) up to $354 million aggregate principal...

MONTRÉAL, Jan. 17, 2023 (GLOBE NEWSWIRE) — Bombardier Inc. (“Bombardier” or the “Company”) today announced an amendment with respect to its cash tender offer previously announced on January 17, 2023 (the “Tender Offer”) to purchase for cash up to $104,000,000 aggregate principal amount (exclusive of accrued and unpaid interest, and as such aggregate principal amount may be increased or decreased by the Company, the “Aggregate Maximum Principal Amount”) of its outstanding 7.50% Senior Notes due 2025 (the “Notes”). Capitalized terms used but not defined herein shall have the meanings assigned to such terms in the Offer to Purchase dated January 17, 2023 (as amended hereby, the “Offer to Purchase”) with respect to the Tender Offer. The Tender Offer and the Offer to Purchase are hereby amended as follows:The Aggregate Maximum Principal...

GUANGZHOU, China, Jan. 17, 2023 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that it expects the Company’s full-year revenue growth for 2022 to be approximately 10% compared to that of 2021. This represents an upward revision compared with the Company’s previous guidance on the full-year revenue growth of 5% as announced on November 15, 2022 in its financial results for the third quarter of 2022. The upward revision of revenue guidance was primarily driven by a better fourth quarter performance compared to the Company’s estimation underlying its previous guidance back in November. The Company currently expects its revenues for the...

SAN DIEGO, Jan. 17, 2023 (GLOBE NEWSWIRE) — American Assets Trust, Inc. (NYSE: AAT) (the “Company”) announced today the tax treatment of its 2022 dividend distributions as follows: Security Descriptions: Common StockCUSIP: 024013104Ticker Symbol: AATRecord Date Payable Date Total Distribution Per Share Allocable to 2022 Taxable Ordinary Dividend LT Capital Gain Unrecaptured Sec. 1250 Gain Section 199A Dividends Return of Capital03/10/22 03/24/22 $0.32 $0.32 $0.294804 $0.000000 $0.000000 $0.294804 $0.02519606/09/22 06/23/22 $0.32 $0.32 $0.294804 $0.000000 $0.000000 $0.294804 $0.02519609/08/22 09/22/22 $0.32 $0.32 $0.294804 $0.000000 $0.000000 $0.294804 $0.02519612/08/22 12/22/22 $0.32 $0.32 $0.294804 $0.000000 $0.000000 $0.294804 $0.025196  Total $1.28 $1.28 $1.179216 $0.000000 $0.000000 $1.179216 $0.100784The...

TORONTO, Jan. 17, 2023 (GLOBE NEWSWIRE) — Freshii Inc. (TSX: FRII) (“Freshii” or the “Company”) today announced that it has filed and is in the process of mailing the Management Information Circular and related materials for the special meeting of Freshii’s shareholders, which will be held virtually at 9:00 a.m. (Toronto time) on February 8, 2023 via live audio webcast as more particularly set out in the meeting materials. At the meeting, shareholders will be asked to consider the previously announced plan of arrangement pursuant to which Foodtastic Inc. will acquire all of the issued and outstanding Class A subordinate voting shares and Class B multiple voting shares in the capital of Freshii and such other business as may properly come before the meeting or any adjournment or postponement thereof. The Circular and related meeting...

TORONTO, Jan. 17, 2023 (GLOBE NEWSWIRE) — SmartCentres Real Estate Investment Trust (“SmartCentres” or the “Trust”) (TSX:SRU.UN) announced today that the trustees of SmartCentres have declared a distribution for the month of January 2023 of CDN $0.15417 per trust unit, representing CDN $1.85 per unit on an annualized basis. Payment will be made on February 15, 2023 to unitholders of record on January 31, 2023. About SmartCentres SmartCentres Real Estate Investment Trust is one of Canada’s largest fully integrated REITs, with a best-in-class portfolio featuring 185 strategically located properties in communities across the country. SmartCentres has approximately $11.9 billion in assets and owns 34.7 million square feet of income producing value-oriented retail and first-class office space with 98.1% occupancy, on 3,500 acres of...